Concentration‐dependent cytoplasmic phase separation of TDP ‐43 drives aggregation and proteinopathy
The FEBS Journal · 2026
DOI: 10.1111/febs.70429 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Pauline Combe und 5 weiteren Autor:innen. Beteiligte Einrichtung: CPCV, Department of Chemistry, École Normale Supérieure, PSL University, Sorbonne Université, CNRS, Paris, France. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Cytoplasm, Protein Aggregation, Pathological, Amyotrophic Lateral Sclerosis. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
TDP‐43 mislocalization and aggregation are common features of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). However, the mechanisms underlying the transition of nuclear TDP‐43 to cytoplasmic aggregates, and their contribution to disease pathogenesis, remain poorly understood. To address this gap, we present a methodology to chemically control the assembly and disassembly of cytoplasmic TDP‐43 condensates. By fusing TDP‐43 to a phase separation–prone protein scaffold, we can induce the formation of cytoplasmic TDP‐43 condensates or, conversely, promote nuclear localization upon addition of a disassembly molecule. TDP‐43 accumulates into various assemblies, ranging from submicrometric puncta to larger aggregate‐like structures that display hallmarks of proteinopathy in a concentration‐dependent manner. Furthermore, oxidative stress drives the maturation of TDP‐43 assemblies from puncta into aggregates through interactions with stress granule components. Finally, we show that cytoplasmic TDP‐43 aggregates deplete nuclear endogenous TDP‐43 and induce cytotoxicity. Collectively, these findings highlight the local cytoplasmic concentration of TDP‐43 and stress exposure as key determinants in the onset of TDP‐43 proteinopathy, providing a relevant model to study pathological TDP‐43 aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CPCV, Department of Chemistry, École Normale Supérieure, PSL University, Sorbonne Université, CNRS, Paris, France.
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, France.
ORCID-Profile: Chloé Subecz, Zoher Gueroui
Förderung
- Fondation pour la Recherche Médicale
Zitieren
APA
Combe, P., Subecz, C., Le Goff, G., Plamont, M. A., Bohl, D., & Gueroui, Z. (2026). Concentration‐dependent cytoplasmic phase separation of TDP ‐43 drives aggregation and proteinopathy. The FEBS Journal. https://doi.org/10.1111/febs.70429
Vancouver
Combe P, Subecz C, Le Goff G, Plamont MA, Bohl D, Gueroui Z. Concentration‐dependent cytoplasmic phase separation of TDP ‐43 drives aggregation and proteinopathy. The FEBS Journal. 2026. doi:10.1111/febs.70429
BibTeX
@article{Combe2026,
author = {Combe, Pauline and Subecz, Chloé and Le Goff, Gaïzka and Plamont, Marie Aude and Bohl, Delphine and Gueroui, Zoher},
title = {Concentration‐dependent cytoplasmic phase separation of TDP ‐43 drives aggregation and proteinopathy},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70429}
}
EUVIMED